New Era for Malignant Pleural Mesothelioma New Era for Malignant Pleural Mesothelioma
The treatment options for malignant pleural mesothelioma are limited, but recent innovations have ushered in a new era in the management of this rare type of cancer.Journal of Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 15, 2022 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Asbestos Found in Talc-Based Tiger Brands Baby Powder
Johnson & Johnson isn’t the only market leader struggling with the issue of asbestos-contaminated talc in its baby powder.
Tiger Brands, the largest food producer in South Africa, has recalled its Purity Essentials Baby Powder as a “precautionary measure,” after trace amounts of asbestos were detected in test samples.
The recall was announced Sept. 8, less than a month after Johnson & Johnson informed company shareholders that it was ending the worldwide sale of its talc-based product in 2023.
Tiger Brands, one of the largest packaged goods companies on the continent, is expected to continue selling ...
Source: Asbestos and Mesothelioma News - September 14, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Source Type: news
Kaiser Study Shows Benefits of Mesothelioma Specialty Centers
Patients diagnosed with pleural mesothelioma are better managed and survive longer when treated at an integrated specialty center, according to a study by Kaiser Permanente that compared its own performance before and after making the transition to specialty care.
Doctors at the Kaiser Permanente Northern California health care system found a dramatic improvement once more specialized and standardized treatment was established for mesothelioma patients.
The Journal of Thoracic Disease published the results of the findings in August.
Mesothelioma patients at Kaiser were three times more likely to receive treatment ...
Source: Asbestos and Mesothelioma News - September 13, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Cancer Center Doctors/Specialists Treatment Source Type: news
Study: ‘ Drug-Factory ’ Technology Kills Mesothelioma Tumor Cells in Mice
Tiny, drug-producing beads implanted in the chest cavity could one day provide a powerful platform that would change the way mesothelioma cancer is treated.
In a recent study, researchers from Rice University and the Baylor College of Medicine demonstrated the implants’ impressive effectiveness in mice, raising hopes of a possible breakthrough for this tough-to-treat cancer.
Researchers have already met with the U.S. Food and Drug Administration, and hope to open a clinical trial to begin testing the procedure’s effectiveness on mesothelioma patients by the second half of 2023. Clinical Cancer Research publis...
Source: Asbestos and Mesothelioma News - August 30, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Source Type: news
Major Section of Libby Asbestos Superfund Cleanup Completed
Twenty years after being placed on the U.S. Environmental Protection Agency’s National Priorities List, the Libby, Montana, asbestos Superfund site continues its slow but steady climb toward total restoration.
The EPA announced earlier this month that cleanup of another major section had been completed, the fourth of a sprawling, eight-unit project that began in 2002.
Operable Unit 6, as this one is officially called, includes railyards owned and operated by BNSF Railway, one of the largest freight railroads in North America. It also encompasses 41 miles of railroad right-of-way through Libby and adjoining Troy, Mo...
Source: Asbestos and Mesothelioma News - August 23, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Mesothelioma Source Type: news
Blood Serum Diagnostic Test for Mesothelioma Explored in Study
One of the biggest obstacles to treating pleural mesothelioma cancer effectively is its often late-stage diagnosis. A recent study shows encouraging signs that those days could be ending.
Novel diagnostic testing using blood serum and infrared spectroscopy is being explored to better characterize and differentiate mesothelioma in its early stages from other lung diseases and benign effusions.
The study is being conducted by scientists and doctors in Ankara and Istanbul, Turkey, spread through various hospitals and university medical centers within the region. Biochimica et Biophysica Acta – Molecular Basis of Disea...
Source: Asbestos and Mesothelioma News - August 22, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Diagnosis Pleural Source Type: news
Verismo Therapeutics Announces Submission of IND Application to the FDA for SynKIR-110TM, a KIR-CAR T-cell Immunotherapy Candidate
Company advances towards in-human clinical trials for SynKIRTM platform targeting Mesothelin-Expressing Advanced Ovarian Cancer, Cholangiocarcinoma, and Mesothelioma
PHILADELPHIA, Aug. 19, 2022 -- (Healthcare Sales & Marketing Network) -- Verismo Thera... Biopharmaceuticals, Oncology Verismo Therapeutics, KIR-CAR, CAR T-cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 19, 2022 Category: Pharmaceuticals Source Type: news
Mesothelioma Clinical Trial Studies Keytruda, Lenvatinib Combination
The objective response rate of the Keytruda/lenvatinib combination was an impressive 58%.
In 2020, the U.S. Food and Drug Administration approved the use of Keytruda for certain metastatic tumors, including certain cases of mesothelioma, but the search for an effective combination continues.
Lenvatinib has shown it can block tumor growth by targeting specific proteins Keytruda can’t reach. It has been effective with only select cancers and is known as precision medicine.
The drug, which is already FDA approved, has been used successfully with Keytruda for the treatment of endometrial cancer. Lenvatinib is prescr...
Source: Asbestos and Mesothelioma News - August 17, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Pleural Source Type: news
Johnson & Johnson Ends Worldwide Sale of Talc-Based Baby Powder
Against the wishes of its shareholders, Johnson & Johnson announced Aug. 11 that it would end the worldwide sale of talc-based Johnson’s Baby Powder in 2023.
The company had already discontinued the sale of the talc-based version of its iconic baby powder in the U.S. and Canada in 2020 when it became the target of thousands of lawsuits. Most claimed J&J’s talc was contaminated with toxic asbestos and causing serious health problems, including mesothelioma and ovarian cancer.
Instead of using talc, the company will transition to a cornstarch-based product, which already is being sold in several countries a...
Source: Asbestos and Mesothelioma News - August 15, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Legal Source Type: news
Camp Lejeune Veterans Win Justice
On Wednesday, Aug. 10, President Joe Biden signed the comprehensive Honoring Our PACT Act of 2022 into law, allowing military veterans and families harmed by contaminated water at Marine Corps Base Camp Lejeune to file lawsuits against the federal government.
The Camp Lejeune Justice Act of 2022, which focuses on four decades of water contamination, is just one part of the much broader PACT Act, which expands access to health care and disability benefits for veterans harmed by toxic exposures around the world.
Biden lauded the bipartisan support for the PACT Act at the signing.
“There are a lot of issues we can...
Source: Asbestos and Mesothelioma News - August 10, 2022 Category: Environmental Health Authors: Chris Elkins Tags: Veterans Source Type: news
Specialty Centers Treating Mesothelioma Lead Best Hospitals Rankings
Mesothelioma specialty programs played a significant role in determining the latest U.S. News & World Report Best Hospitals for Cancer Care annual rankings.
For the eighth consecutive year, MD Anderson Cancer Center in Houston was ranked No. 1, followed by Memorial Sloan Kettering in New York; Mayo Clinic in Rochester, Minnesota; Dana Farber/Brigham and Women’s in Boston and UCLA Medical Center in Los Angeles.
“This ranking is a reminder of our responsibility to those we serve, and it drives our unwavering commitment to our mission to end cancer,” said Dr. Peter WT Pisters, president of MD Anderson. “We a...
Source: Asbestos and Mesothelioma News - August 10, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Doctors/Specialists Mesothelioma Treatment Source Type: news
Study Suggests Relationship Between Stromal Tumors and Mesothelioma
Early identification of peritoneal mesothelioma cancer – when it is most effectively treated – may become more common after a recent study revealed a potential link to gastrointestinal stromal tumors.
A single-center retrospective review by the division of surgical oncology at University of California San Diego Moores Cancer Center identified a previously underrecognized, synchronous co-occurrence between the two rare diseases.
Annals of Surgical Oncology published the case series in July, which found that one in every 17 patients undergoing resection for gastrointestinal stromal tumors, known as GISTs, also had ...
Source: Asbestos and Mesothelioma News - August 2, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Peritoneal Source Type: news
Malignant Mesothelioma Mortality in Women Malignant Mesothelioma Mortality in Women
While malignant mesothelioma is usually associated with men due to occupational exposure to asbestos, cases among women are on the rise, according to this CDC report.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 1, 2022 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
WHO Reclassifies Firefighting as High-Risk Occupation for Cancer
The World Health Organization has reclassified firefighting to its highest level of occupational risk for cancer after extensive research confirmed an alarming level of malignant mesothelioma incidence.
The International Agency for Research on Cancer, which is part of WHO, found that firefighters had a 58% higher risk than the general population of developing mesothelioma, a rare cancer caused by exposure to asbestos fibers.
These findings led to the occupation being reclassified recently as “carcinogenic to humans,” earning it Group 1 status for cancer risk and confirming what many already believed.
“This r...
Source: Asbestos and Mesothelioma News - July 28, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Mesothelioma Source Type: news
UK Approves Opdivo/Yervoy Immunotherapy for Pleural Mesothelioma
Patients with unresectable pleural mesothelioma cancer throughout the United Kingdom will now have the immunotherapy combination of Opdivo and Yervoy as an option after its recent approval by the National Health Service for first-line treatment.
The long-awaited approval comes almost two years after the U.S. Food and Drug Administration granted a similar approval of Opdivo and Yervoy. It brings new hope to a region particularly hard hit by this rare cancer caused primarily by exposure to asbestos.
Opdivo and Yervoy, known generically as nivolumab and ipilimumab, respectively, are manufactured by Bristol Myers Squibb....
Source: Asbestos and Mesothelioma News - July 27, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Immunotherapy Mesothelioma Treatment Source Type: news
